Usually, robot-assisted surgical endoscopy is feasible by technical means. This robot-assisted surgical endoscopy appears to simplify the most complex procedures by improving the overall exposure, visualization, and tissue manipulation processes. It has the entire potential to reduce the learning curve and broaden the overall adoption of the challenging procedures involving suturing, tissue dissection, and other crucial techniques. Also, the Robotic-assisted colonoscopy is well intended to improvise the patient’s exam tolerance, reduce pain, reduce the risk of perforation and promote the cecal intubation regardless of the endoscopist's capability. In addition, for all those where it is necessary for the colonoscope to have the active motion and to mould to the colon. With the help of robotic assistance, the physician could easily manipulate the colonoscope within a specific distance. In accordance with the UK’s NED (National Endoscopy Database), an average of about 35,478 endoscopy procedures were conducted per week by around 3007 endoscopists, which signifies 12 procedures per endoscopist.
The overall process of Endoscopy began as a gastrointestinal (GI) diagnosis method, and it has become a significant treatment method for GI pathologies in recent times. The device or the equipment has been in constant evolution since the implementation of the electric lamp, the coming of the flexible endoscopes, the recent development of robotic methods and the incorporation of ultrasonography.
Endoscopic devices or the instruments had already been utilized for the bladder, urethra, and uterine cervix. However, in 1868, it was Adolf Kussmaul who had performed the 1st direct esophagogastroscopy. After attending a sword-swallower performance, he had demonstrated that it was possible to launch a rigid tube to the stomach if the neck and head hyperextended, though without any sufficient illumination. Joseph Leiter, in the year 1882, had included an electrical lamp on the extreme tip of the endoscope.
In 2020, the overall valuation of the Global Robotic Endoscopy Devices Market was around USD 1.40 billion. It is anticipated to reach around USD 5.49 billion by 2030, representing an overall CAGR of 14.65 percent throughout the forecasted period.
Recent Developments in the Robotic Endoscopy Devices Market
In the month of June 2021, Johnson & Johnson (US) launched the ENSEAL X1 Curved Jaw Tissue Sealer. This advanced bipolar energy device increments the procedural efficiency and offers more robust sealing & access to various body tissues. It is an intuitive and intelligent device that offers more secure sealing and ease of use that improvises the currently available advanced bipolar sealing devices.
Olympus Corporation (Japan) had paid an overall sum of USD 300 million in the month of May 2021 for Medi-Tate Ltd. (Israel), which had offered Olympus in-office therapy for benign prostatic hyperplasia (BPH) to extend its business line in-office treatment for the treatment of benign prostatic hyperplasia and to solidify its entire position as a leader in the domain of urological devices.
Endoscopy, which is widely known in recent times, is mainly because of the invention of the flexible endoscope by Schindler and Wolf in the year 1932, spreading the overall usage of diagnostic endoscopy. Moreover, the emergence of technology like video-endoscopy has extended its utilization in the entire treatment of GI pathologies.
Moreover, with the propagation and evolution of endoscopy, two major dilemmas have emerged in recent times. Both the willingness to conduct NOTES (Natural Orifice Transluminal Endoscopic Surgeries) and the ESD (endoscopic submucosal dissection), resecting the lesions each time complex and wider, bring the requirement of the platforms that promote forceps manipulation and stability that the conventional equipment does not. Also, in adding up to that, there is the ultimate pursuit of automation for the equipment to do what, nowadays, only the endoscopist physician is competent.